EW — Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation NYSE

Healthcare ·Medical - Devices ·US · edwards.com

$83.98

Mkt Cap $49.2B

52w Low $72.30 74.9% of range 52w High $87.89

50d MA $81.94 200d MA $80.98

P/E (TTM) 45.6x

EV/EBITDA 33.3x

P/B 4.8x

Debt/Equity 0.1x

ROE 10.4%

P/FCF 37.3x

RSI (14) —

ATR (14) —

Beta 0.94

50d MA $81.94

200d MA $80.98

Avg Volume 5.2M

About

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricusp…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 23, 2026	AMC	0.73	0.78	+7.0%	79.72	+3.5%	+5.6%	+4.7%	+3.2%	+1.9%	+4.7%	—	—
Feb 10, 2026	AMC	0.62	0.58	-6.1%	77.05	+2.0%	+3.0%	-0.8%	-1.5%	+1.8%	+2.5%	+9.8%	—
Oct 30, 2025	AMC	0.60	0.67	+12.4%	83.48	+1.2%	-1.2%	-0.5%	+0.8%	-0.8%	-1.2%	+2.1%	—
Jul 24, 2025	AMC	0.62	0.67	+7.4%	75.80	+7.5%	+5.5%	+3.5%	+6.2%	+7.1%	+4.6%	+6.7%	—
Apr 23, 2025	AMC	0.60	0.64	+7.4%	70.46	+5.3%	+6.6%	+7.9%	+7.2%	+8.3%	+7.1%	+6.4%	—
Feb 11, 2025	AMC	0.55	0.59	+7.1%	70.91	+4.4%	+6.9%	+7.2%	+7.4%	+6.7%	+5.3%	-4.2%	—
Oct 24, 2024	AMC	0.67	0.67	+0.8%	70.35	-2.1%	-1.4%	-2.6%	-1.4%	-2.4%	-4.7%	+1.3%	—
Jul 24, 2024	AMC	0.69	0.70	+1.4%	86.95	-26.4%	-31.3%	-28.3%	-26.7%	-26.8%	-27.5%	-18.5%	—
Apr 25, 2024	AMC	0.64	0.66	+3.1%	88.01	-1.1%	-1.8%	-2.3%	-3.8%	-4.2%	-3.4%	-1.1%	—
Feb 6, 2024	AMC	0.64	0.64	+0.0%	88.25	+1.3%	-1.9%	-2.8%	-3.7%	-1.3%	-2.3%	+6.3%	—
Oct 25, 2023	AMC	0.59	0.59	+0.0%	68.34	-8.5%	-8.1%	-9.7%	-8.8%	-6.8%	-6.6%	-0.6%	—
Jul 26, 2023	AMC	0.65	0.66	+1.5%	91.63	-5.1%	-9.8%	-8.6%	-10.4%	-10.5%	-12.3%	-16.9%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 27	Barclays	Maintains	Overweight → Overweight	—	$84.15	$83.54	-0.7%	-0.8%	-2.2%	-3.5%	-0.8%	-0.2%
Apr 24	Truist	Maintains	Hold → Hold	—	$79.72	$82.50	+3.5%	+5.6%	+4.7%	+3.2%	+1.9%	+4.7%
Apr 24	Evercore ISI	Maintains	Outperform → Outperform	—	$79.72	$82.50	+3.5%	+5.6%	+4.7%	+3.2%	+1.9%	+4.7%
Apr 24	Baird	Maintains	Neutral → Neutral	—	$79.72	$82.50	+3.5%	+5.6%	+4.7%	+3.2%	+1.9%	+4.7%
Apr 24	BTIG	Maintains	Buy → Buy	—	$79.72	$82.50	+3.5%	+5.6%	+4.7%	+3.2%	+1.9%	+4.7%
Apr 24	Canaccord Genuity	Maintains	Hold → Hold	—	$79.72	$82.50	+3.5%	+5.6%	+4.7%	+3.2%	+1.9%	+4.7%
Apr 13	Mizuho	Maintains	Outperform → Outperform	—	$77.87	$77.57	-0.4%	+0.3%	+0.4%	+0.4%	+1.5%	+4.0%
Apr 6	Evercore ISI	Maintains	Outperform → Outperform	—	$81.05	$81.00	-0.1%	+0.2%	-0.3%	+0.8%	-2.3%	-3.9%
Feb 11	BTIG	Maintains	Buy → Buy	—	$77.05	$78.61	+2.0%	+3.0%	-0.8%	-1.5%	+1.8%	+2.5%
Feb 11	Goldman Sachs	Maintains	Buy → Buy	—	$77.05	$78.61	+2.0%	+3.0%	-0.8%	-1.5%	+1.8%	+2.5%
Feb 11	Piper Sandler	Maintains	Overweight → Overweight	—	$77.05	$78.61	+2.0%	+3.0%	-0.8%	-1.5%	+1.8%	+2.5%
Feb 11	Truist	Maintains	Hold → Hold	—	$77.05	$78.61	+2.0%	+3.0%	-0.8%	-1.5%	+1.8%	+2.5%
Feb 11	Wells Fargo	Maintains	Overweight → Overweight	—	$77.05	$78.61	+2.0%	+3.0%	-0.8%	-1.5%	+1.8%	+2.5%
Jan 20	Piper Sandler	Maintains	Overweight → Overweight	—	$84.35	$83.73	-0.7%	-1.1%	+0.9%	+0.1%	-0.8%	-0.1%
Jan 20	Stifel	Maintains	Buy → Buy	—	$84.35	$83.73	-0.7%	-1.1%	+0.9%	+0.1%	-0.8%	-0.1%
Jan 12	Barclays	Maintains	Overweight → Overweight	—	$85.13	$86.00	+1.0%	-2.5%	-1.5%	-2.4%	-0.8%	-0.9%
Jan 12	UBS	Maintains	Neutral → Neutral	—	$85.13	$86.00	+1.0%	-2.5%	-1.5%	-2.4%	-0.8%	-0.9%
Jan 9	TD Cowen	Upgrade	Hold → Buy	—	$84.58	$85.28	+0.8%	+0.7%	-1.9%	-0.9%	-1.7%	-0.1%
Jan 7	Stifel	Maintains	Buy → Buy	—	$85.85	$86.27	+0.5%	-1.2%	-1.5%	-0.8%	-3.3%	-2.3%
Dec 18	JP Morgan	Upgrade	Neutral → Overweight	—	$84.84	$85.83	+1.2%	-0.0%	+1.0%	+2.0%	+1.6%	+1.7%
Dec 17	Canaccord Genuity	Maintains	Hold → Hold	—	$85.32	$85.76	+0.5%	-0.6%	-0.6%	+0.4%	+1.4%	+1.1%
Dec 16	Baird	Maintains	Neutral → Neutral	—	$83.38	$83.16	-0.3%	+2.3%	+1.8%	+1.7%	+2.7%	+3.8%
Dec 11	Citigroup	Maintains	Buy → Buy	—	$83.92	$84.35	+0.5%	+0.4%	-1.0%	-0.6%	+1.7%	+1.1%
Dec 8	Barclays	Maintains	Overweight → Overweight	—	$86.19	$86.01	-0.2%	-2.2%	-3.4%	-2.6%	-2.3%	-3.6%
Dec 5	UBS	Maintains	Neutral → Neutral	—	$85.78	$86.31	+0.6%	+0.5%	-1.7%	-2.9%	-2.2%	-1.8%
Dec 5	Wells Fargo	Maintains	Overweight → Overweight	—	$85.78	$86.31	+0.6%	+0.5%	-1.7%	-2.9%	-2.2%	-1.8%
Dec 5	RBC Capital	Maintains	Outperform → Outperform	—	$85.78	$86.31	+0.6%	+0.5%	-1.7%	-2.9%	-2.2%	-1.8%
Dec 5	BTIG	Maintains	Buy → Buy	—	$85.78	$86.31	+0.6%	+0.5%	-1.7%	-2.9%	-2.2%	-1.8%
Dec 5	Baird	Maintains	Neutral → Neutral	—	$85.78	$86.31	+0.6%	+0.5%	-1.7%	-2.9%	-2.2%	-1.8%
Dec 5	Truist	Maintains	Hold → Hold	—	$85.78	$86.31	+0.6%	+0.5%	-1.7%	-2.9%	-2.2%	-1.8%
Dec 5	Stifel	Maintains	Buy → Buy	—	$85.78	$86.31	+0.6%	+0.5%	-1.7%	-2.9%	-2.2%	-1.8%
Dec 5	Canaccord Genuity	Maintains	Hold → Hold	—	$85.78	$86.31	+0.6%	+0.5%	-1.7%	-2.9%	-2.2%	-1.8%
Nov 25	BTIG	Maintains	Buy → Buy	—	$84.71	$84.66	-0.1%	+2.5%	+2.4%	+2.3%	+0.7%	+0.0%
Nov 3	Canaccord Genuity	Maintains	Hold → Hold	—	$82.45	$83.41	+1.2%	+0.8%	+2.1%	+0.5%	-0.0%	+1.1%
Nov 3	Truist	Maintains	Hold → Hold	—	$82.45	$83.41	+1.2%	+0.8%	+2.1%	+0.5%	-0.0%	+1.1%
Oct 31	Goldman Sachs	Maintains	Buy → Buy	—	$83.48	$84.48	+1.2%	-1.2%	-0.5%	+0.8%	-0.8%	-1.2%
Oct 31	Piper Sandler	Maintains	Overweight → Overweight	—	$83.48	$84.48	+1.2%	-1.2%	-0.5%	+0.8%	-0.8%	-1.2%
Oct 31	Stifel	Maintains	Buy → Buy	—	$83.48	$84.48	+1.2%	-1.2%	-0.5%	+0.8%	-0.8%	-1.2%
Oct 31	Citigroup	Maintains	Buy → Buy	—	$83.48	$84.48	+1.2%	-1.2%	-0.5%	+0.8%	-0.8%	-1.2%
Oct 31	Barclays	Maintains	Overweight → Overweight	—	$83.48	$84.48	+1.2%	-1.2%	-0.5%	+0.8%	-0.8%	-1.2%
Oct 31	RBC Capital	Maintains	Outperform → Outperform	—	$83.48	$84.48	+1.2%	-1.2%	-0.5%	+0.8%	-0.8%	-1.2%
Oct 31	Evercore ISI	Maintains	Outperform → Outperform	—	$83.48	$84.48	+1.2%	-1.2%	-0.5%	+0.8%	-0.8%	-1.2%
Oct 31	Mizuho	Maintains	Outperform → Outperform	—	$83.48	$84.48	+1.2%	-1.2%	-0.5%	+0.8%	-0.8%	-1.2%
Oct 31	JP Morgan	Maintains	Neutral → Neutral	—	$83.48	$84.48	+1.2%	-1.2%	-0.5%	+0.8%	-0.8%	-1.2%
Oct 29	Wolfe Research	Upgrade	Underperform → Peer Perform	—	$82.19	$84.50	+2.8%	+0.6%	+1.6%	+0.3%	+1.1%	+2.4%
Oct 29	Jefferies	Upgrade	Hold → Buy	—	$82.19	$84.50	+2.8%	+0.6%	+1.6%	+0.3%	+1.1%	+2.4%
Oct 28	Truist	Maintains	Hold → Hold	—	$80.82	$80.17	-0.8%	+1.7%	+2.3%	+3.3%	+2.0%	+2.8%
Oct 8	Oppenheimer	Downgrade	Outperform → Perform	—	$76.72	$74.50	-2.9%	-1.3%	-2.0%	-3.6%	-4.9%	-4.4%
Oct 7	Evercore ISI	Upgrade	In Line → Outperform	—	$76.56	$77.85	+1.7%	+0.2%	-1.1%	-1.8%	-3.4%	-4.7%
Sep 22	Stifel	Maintains	Buy → Buy	—	$74.41	$74.20	-0.3%	-0.9%	+0.2%	+0.3%	+1.2%	+2.5%

Recent Filings

8-K

Edwards Lifesciences Corp -- 8-K Filing

Edwards Lifesciences reported Q1 2026 results, with CEO Bernard Zovighian reaffirming the company's strategic focus on structural heart disease innovation and addressing complex patient needs.

Apr 23

8-K

Edwards Lifesciences Corp -- 8-K Filing

Edwards Lifesciences reported strong fourth-quarter results and raised its 2026 outlook, citing confidence in sustained growth from its valve innovation expertise and clinical evidence.

Feb 10

Data updated apr 25, 2026 8:05am · Source: massive.com